Click Here to ParticipateRecorded on: February 25, 2025Estimated Time to Complete: 2.5 hours2.5 CE Credits/Contact hours for nurses and social workers…
Education Resources
Click Here to ParticipateRecorded on: February 4, 2025Estimated Time to Complete: 1.75 hours1.75 CE Credits/Contact hours for nurses and social worker…
Education Resources
This activity is intended for physicians, physician assistants/associates, and nurses engaged in the care of patients with hematologic malignancies.
Education Resources
View on PR Newswire here.
Please join The Leukemia & Lymphoma Society for a webcast for patients and caregivers. We invite you to learn more about: -Treatment options for CLL…
Topics Covered We invite you to learn more about: Treatment options for CLL Side-effects management Ways to effectively communicate with your he…
Table of contents: What causes acute myeloid leukemia?What is AML?Role of bone marrow and white blood cellsHow leukemia interferes with blood cell cou…
North Carolina Gov. Roy Cooper just signed Medicaid expansion into law, following years of advocacy from LLS volunteers and staff. Once it takes effec…
Table of contents: Understanding AML vs. ALL: Navigating the complex fieldSimilarities and differences between AML and ALLCauses and risk factors: Und…
Join us in thanking Walgreens stores and customers across the country for raising over $6 million for LLS and Susan G. Komen during their spring campa…
hypothesize that demonstrating activity of CLL-1 CAR-T (CLL1CART) cell therapy with or without trametinib in pre-clinical models of chronic myelomonoc…
Lund, Sweden – March 20, 2025 – BioInvent International AB (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and development of nov…
Advocacy
The U.S. Food and Drug Administration (FDA) today announced approval of a new CAR T-cell treatment for adult patients with certain forms of relapsed/r…
Part of the The Caring for Kids And Adolescents with Blood Cancer workbook, which provides information for caregivers of child and adolescent patients.
Caregivers may order a copy of the full workbook by calling (800) 955-4572.
Part of the The Caregiver Workbook, which provides information for caregivers of adult patients.
Caregivers may order a copy of the full workbook by calling (800) 955-4572.
Blood cancer treatment can be a scary and confusing time. And blood cancer patients want to feel like they’re not alone. That’s why The Leukemia & Lym…
BOULDER, Colo., July 23, 2020 - miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and dev…
Table of contents:Living with CLL: symptoms, treatment, & supportWhat is CLLCLL stagesCLL symptomsCLL testing and diagnosisCLL treatmentPrognosi…
Live, interactive, case based discussion - free CME/CE seriesSession 1: Rapid Diagnosis, Risk Stratification, and Induction Therapies – September 17, …
Cancer treatments can be lifesaving. As an organization, The Leukemia & Lymphoma Society (LLS) has invested more than $1.7 billion in blood cancer res…
Hairy cell leukemia (HCL) is very sensitive to chemotherapy, whose toxicity to the bone marrow and the immune system is however concerning. We have es…
We have identified the multi-domain protein DCAF1 as a genetic dependency in multiple myeloma and developed a series of potent on-target DCAF1 inhibit…
On January 15, the U.S. Food and Drug Administration (FDA) announced approval of daratumumab plus hyaluronidase (Darzalex Faspro®) for adults with new…
The therapeutic landscape of acute myeloid leukemia (AML) has witnessed considerable expansion following recent U.S. FDA endorsements of novel therapi…
The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.